Komori
Financial Results Presentation9158CUC Inc.Information and Communications, Services and Others

First-Quarter Financial Results Presentation for the Fiscal Year Ending March 2027

Revenue increased 9.0% year on year as all segments expanded. However, EBITDA and operating profit declined significantly due to upfront investments in home-visit nursing, the U.S. OBL business, and new hospice openings.

Worth reading
85Important
Scored from 5 of 6 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
-95.7
Year-on-year change in operating profit (%)
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial Results PresentationFirst quarter of the fiscal year ending March 20279 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales14,159 Millions of yen+9.0%
Operating profit32 Millions of yen-95.7%
Net income-281 Millions of yen
Results for the three months of the current quarterRevenue of ¥14,159 million, EBITDA of ¥1,225 million, operating profit of ¥32 million, and profit for the period attributable to owners of the parent of ¥281 million loss. Segment revenue, EBITDA, and operating profit are also presented on a standalone basis for the three months of the quarter.
Full-year earnings forecast
Revenue
64,600 Millions of yen
EBITDA
9,700 Millions of yen
Operating profit
3,800 Millions of yen
Profit for the period attributable to owners of the parent
1,100 Millions of yen
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Revenue21.9%
Healthcare institution revenue21.7%
Domestic healthcare institution revenue24.4%
Overseas healthcare institution revenue18.8%
Hospice revenue21.6%
Home-visit nursing revenue23.8%
Medical Care Residence revenue23.0%
EBITDA12.6%
Healthcare institution EBITDA16.6%
Hospice EBITDA12.9%
Home-visit nursing EBITDA8.5%
Medical Care Residence EBITDA15.5%
Operating profit0.8%
Healthcare institution operating profit15.5%
Domestic healthcare institution operating profit23.6%
Home-visit nursing operating profit9.1%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Revenue and profit are generally tracking in line with the plan. Domestic healthcare institutions exceeded the plan, overseas healthcare institutions fell short, hospice revenue fell short while profit was in line with the plan, and Medical Care Residence fell slightly short on both revenue and profit.
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Year-on-year change in revenue
Medical institutions in Japan121 Millions of yen
Medical institutions overseas-98 Millions of yen
Hospice225 Millions of yen
Home-Visit Nursing167 Millions of yen
Medical Care Residences455 Millions of yen
Other and adjustments19 Millions of yen
Year-on-year change in EBITDA
Medical institutions in Japan121 Millions of yen
Medical institutions overseas-98 Millions of yen
Hospice10 Millions of yen
Home-Visit Nursing-245 Millions of yen
Medical Care Residences85 Millions of yen
Other and adjustments-28 Millions of yen
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Exchange rate for the fiscal year ending March 2027Approximately ¥155 to the U.S. dollar (average for the period)
Exchange rate for the first quarter of the fiscal year ending March 2027Approximately ¥159 to the U.S. dollar (average for the period)
New initiatives
  • Strategic business alliance with doctors Okuno and Osman in the U.S. OBL business
  • Making 株式会社ライブラ a consolidated subsidiary
  • Opening 7 new home-visit nursing stations
  • Improving hospice occupancy rates, optimizing operations, and reviewing prices for self-pay services
Key KPIsA metric the company considers important as a management benchmark.
  • Number of key locations supporting medical institutions in Japan167 Location+5.7%
  • Number of U.S. patients64,460 people+0.6%
  • Number of hospice facilities67 Facility+26.4%
  • Hospice capacity2,318 people+31.3%
  • Hospice occupancy rate83.7 %-1.5%
  • Number of home-visit nursing users15,445 people+3.8%
  • Total home-visit nursing care hours330 Thousand hours+4.0%
  • Full-time equivalent nurses and therapists1,313 people+10.1%
  • Medical Care Residence occupancy rate76.8 %-3.2%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
United States
Number of patients
64,460 people+0.6%
Revenue per patient
¥28,472+13.3%
Hospice
Annual revenue per resident
8.1 Millions of yen-5.4%
Medical Care Residences
Annual revenue per resident
4.9 Millions of yen+9.2%
Segment results
Medical institutions
Revenue
4,510 Millions of yen+9.1%
EBITDA
671 Millions of yen-28.9%
Operating profit
381 Millions of yen
Hospice
Revenue
4,447 Millions of yen+16.0%
EBITDA
316 Millions of yen+6.0%
Operating profit
-102 Millions of yen
Home-Visit Nursing
Revenue
3,302 Millions of yen+2.3%
EBITDA
131 Millions of yen-70.0%
Operating profit
91 Millions of yen
Medical Care Residences
Revenue
1,923 Millions of yen+5.5%
EBITDA
334 Millions of yen+34.2%
Operating profit
-93 Millions of yen
Other and adjustments
Revenue
-22 Millions of yen
EBITDA
-227 Millions of yen
Operating profit
-245 Millions of yen
Number of stores and locations
Seven home-visit nursing stations were newly opened, bringing the nationwide total to 102 locations. The number of major support locations for domestic healthcare institutions was 167. The number of hospice facilities was 67.
Capital expenditures
1,914 Millions of yen
Contents of this document
ItemDetails
Document typeFinancial Results Presentation
Fiscal Period CoveredFirst quarter of the fiscal year ending March 2027
Net Sales14,159 Millions of yen (YoY +9.0%)
Operating profit32 Millions of yen (YoY -95.7%)
Net income-281 Millions of yen
Results for the three months of the current quarterRevenue of ¥14,159 million, EBITDA of ¥1,225 million, operating profit of ¥32 million, and profit for the period attributable to owners of the parent of ¥281 million loss. Segment revenue, EBITDA, and operating profit are also presented on a standalone basis for the three months of the quarter.
Full-year earnings forecastRevenue 64,600 Millions of yen / EBITDA 9,700 Millions of yen / Operating profit 3,800 Millions of yen / Profit for the period attributable to owners of the parent 1,100 Millions of yen
Progress against full-year forecastRevenue 21.9% / Healthcare institution revenue 21.7% / Domestic healthcare institution revenue 24.4% / Overseas healthcare institution revenue 18.8% / Hospice revenue 21.6% / Home-visit nursing revenue 23.8% / Medical Care Residence revenue 23.0% / EBITDA 12.6% / Healthcare institution EBITDA 16.6% / Hospice EBITDA 12.9% / Home-visit nursing EBITDA 8.5% / Medical Care Residence EBITDA 15.5% / Operating profit 0.8% / Healthcare institution operating profit 15.5% / Domestic healthcare institution operating profit 23.6% / Home-visit nursing operating profit 9.1%
Self-assessment against the planRevenue and profit are generally tracking in line with the plan. Domestic healthcare institutions exceeded the plan, overseas healthcare institutions fell short, hospice revenue fell short while profit was in line with the plan, and Medical Care Residence fell slightly short on both revenue and profit.
Segment resultsMedical institutions Revenue 4,510 Millions of yen (YoY +9.1%) / EBITDA 671 Millions of yen (YoY -28.9%) / Operating profit 381 Millions of yen / Hospice Revenue 4,447 Millions of yen (YoY +16.0%) / EBITDA 316 Millions of yen (YoY +6.0%) / Operating profit -102 Millions of yen / Home-Visit Nursing Revenue 3,302 Millions of yen (YoY +2.3%) / EBITDA 131 Millions of yen (YoY -70.0%) / Operating profit 91 Millions of yen / Medical Care Residences Revenue 1,923 Millions of yen (YoY +5.5%) / EBITDA 334 Millions of yen (YoY +34.2%) / Operating profit -93 Millions of yen / Other and adjustments Revenue -22 Millions of yen / EBITDA -227 Millions of yen / Operating profit -245 Millions of yen
Breakdown of Factors Affecting the ChangeYear-on-year change in revenue Medical institutions in Japan 121 Millions of yen / Medical institutions overseas -98 Millions of yen / Hospice 225 Millions of yen / Home-Visit Nursing 167 Millions of yen / Medical Care Residences 455 Millions of yen / Other and adjustments 19 Millions of yen / Year-on-year change in EBITDA Medical institutions in Japan 121 Millions of yen / Medical institutions overseas -98 Millions of yen / Hospice 10 Millions of yen / Home-Visit Nursing -245 Millions of yen / Medical Care Residences 85 Millions of yen / Other and adjustments -28 Millions of yen
Key KPIsNumber of key locations supporting medical institutions in Japan 167 Location (YoY +5.7%), Number of U.S. patients 64,460 people (YoY +0.6%), Number of hospice facilities 67 Facility (YoY +26.4%), Hospice capacity 2,318 people (YoY +31.3%), Hospice occupancy rate 83.7 % (YoY -1.5%), Number of home-visit nursing users 15,445 people (YoY +3.8%), Total home-visit nursing care hours 330 Thousand hours (YoY +4.0%), Full-time equivalent nurses and therapists 1,313 people (YoY +10.1%), Medical Care Residence occupancy rate 76.8 % (YoY -3.2%)
Unit price and quantity metricsUnited States Number of patients 64,460 people (YoY +0.6%) / Revenue per patient ¥28,472 (YoY +13.3%) / Hospice Annual revenue per resident 8.1 Millions of yen (YoY -5.4%) / Medical Care Residences Annual revenue per resident 4.9 Millions of yen (YoY +9.2%)
Number of stores and locationsSeven home-visit nursing stations were newly opened, bringing the nationwide total to 102 locations. The number of major support locations for domestic healthcare institutions was 167. The number of hospice facilities was 67.
Assumptions Underlying the Business OutlookExchange rate for the fiscal year ending March 2027 Approximately ¥155 to the U.S. dollar (average for the period) / Exchange rate for the first quarter of the fiscal year ending March 2027 Approximately ¥159 to the U.S. dollar (average for the period)
Capital expenditures1,914 Millions of yen
New initiativesStrategic business alliance with doctors Okuno and Osman in the U.S. OBL business, Making 株式会社ライブラ a consolidated subsidiary, Opening 7 new home-visit nursing stations, Improving hospice occupancy rates, optimizing operations, and reviewing prices for self-pay services
Items this document does not state (14)
Ordinary incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Profit declined due to upfront investments, including higher personnel and recruitment costs associated with opening new home-visit nursing stations and expanding existing stations, costs to prepare for openings in the U.S. OBL business, and costs related to new hospice openings.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
First-Quarter Financial Results Presentation for the Fiscal Year Ending March 2027 | CUC Inc. (9158) timely disclosure | Komori